These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 25968946)

  • 1. Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease.
    Tripathy D; Chakraborty J; Mohanakumar KP
    Free Radic Res; 2015; 49(9):1129-39. PubMed ID: 25968946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.
    Ebadi M; Sharma SK
    Antioxid Redox Signal; 2003 Jun; 5(3):319-35. PubMed ID: 12880486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
    FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
    Shavali S; Combs CK; Ebadi M
    Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B; Dluzen DE
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.
    Kim SR; Chung ES; Bok E; Baik HH; Chung YC; Won SY; Joe E; Kim TH; Kim SS; Jin MY; Choi SH; Jin BK
    J Neurosci Res; 2010 May; 88(7):1537-48. PubMed ID: 20025058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
    Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
    Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
    Jung UJ; Jeon MT; Choi MS; Kim SR
    J Med Food; 2014 May; 17(5):599-605. PubMed ID: 24660866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia.
    Ryu JK; Shin WH; Kim J; Joe EH; Lee YB; Cho KG; Oh YJ; Kim SU; Jin BK
    Glia; 2002 Apr; 38(1):15-23. PubMed ID: 11921200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
    Chung YC; Kim SR; Jin BK
    J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.
    Kim HG; Ju MS; Kim DH; Hong J; Cho SH; Cho KH; Park W; Lee EH; Kim SY; Oh MS
    Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):958-64. PubMed ID: 20629656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
    Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
    Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Acetyl-7-hydroxy-6-methoxy-1-methyl-1,2,3,4,-tetrahydroisoquinoline exhibits anti-inflammatory properties and protects the nigral dopaminergic neurons.
    Son HJ; Han SH; Lee JA; Lee CS; Seo JW; Chi DY; Hwang O
    Eur J Pharmacol; 2016 Jan; 771():152-61. PubMed ID: 26687634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
    Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
    Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.
    Kostrzewa RM; Kostrzewa JP; Brus R
    Amino Acids; 2002; 23(1-3):57-63. PubMed ID: 12373519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
    Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
    J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.